What CD Genomics does

CD Genomics is a private US-based biotechnology services company headquartered in Shirley, with 51-100 employees, that provides omics laboratory services to academic, biotechnology, pharmaceutical, and contract research clients globally. The company operates a multi-platform sequencing services business spanning next-generation sequencing on Illumina platforms, long-read PacBio SMRT sequencing (PacBio Sequel, with average read lengths up to 15 kb and longest reads of 40-60 kb), and Oxford Nanopore sequencing on PromethION/GridION systems using Kit 14 chemistry and R10.4.1 flow cells. Service categories include genomics, transcriptomics, epigenomics (over 16 technologies such as WGBS, ChIP-Seq, ATAC-Seq, MeRIP, CUT&Tag), microbiome, single-cell, spatial multi-omics (Stereo-seq, 10x Xenium/Visium HD/FF), genotyping, population genetics, microarray, and CRISPR sequencing. The company also offers standalone bioinformatics analysis and a productized Bioinformatics Cloud Platform.

Revenue is generated primarily through project-based professional services priced on a quote basis via an online instant-quote system, with 30-day invoicing. The go-to-market is digital-first, with a multi-language website (English, German, French, Portuguese), direct online ordering, and a sales-and-consultation layer organized into customer service, sales, and scientific assistant departments. Marketing channels include SEO, paid social and display (Google, Bing, Facebook, LinkedIn), email, content marketing through case studies and peer-reviewed publications, and industry conferences. Named customers span NIH, UC San Diego, Harvard, Oxford, UCLA, University of Pennsylvania, Kent State, Thomas Jefferson University, Singapore Institute for Clinical Sciences, Universidade de Lisboa, TU Dortmund, Universidad Nacional del Sur, and Novome Biotechnologies. Recent strategic emphasis is on advanced long-read and single-cell applications, including a February 2026 launch of a Microbial Single-Cell Sequencing Service based on proprietary MobiNova-100 and MobiNova-M1 systems, and a TAIL Iso-seq service for poly(A) tail and alternative polyadenylation analysis. The company is privately held with no disclosed institutional funding, parent company, or management team information in the source data.

Name

CD Genomics

Legal name

CD Genomics

Website

https://cd-genomics.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

CD Genomics is a private US-based multi-platform omics services provider (51-100 employees) offering Illumina NGS, PacBio SMRT, and Oxford Nanopore sequencing, plus genotyping, microarray, single-cell, spatial multi-omics, and bioinformatics services to academic, biotech, pharma, and CRO clients globally on a quote-based project model.

Ownership category

akta.pro rank

Product category

Genomics Sequencing & Bioinformatics Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Companion Diagnostics (CDx) Development & Trial Testing Support (HLAGAEAJ), Gene Therapy Vector Manufacturing & CDMO Services (HLAAACAJ)

Keywords

• DNA sequencing services
• Genotyping services
• Bioinformatics analysis
• Long-read sequencing
• Microarray services

Headquarters

HQ city

Shirley

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Sequencing Services Revenue: CD Genomics generates revenue primarily through providing DNA and RNA sequencing services. They offer both standard and specialized sequencing services across multiple technology platforms (Illumina, PacBio, Nanopore). Revenue is generated per project/sample with pricing based on sequencing type, throughput, and bioinformatics analysis requirements. The company provides quote-based pricing through their 'Get Your Instant Quote' system.
2. Bioinformatics Services: NGS data or long read data analysis and interpretation services as standalone or bundled offerings. Includes genomic data analysis, transcriptomic data analysis, epigenomics data analysis, and long-read sequencing data analysis services.
3. Microarray Services: Transcriptomics microarray, genomics microarray, DNA methylation microarray, and Global Diversity Array services providing gene expression profiling and genetic analysis capabilities.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

CD Genomics provides comprehensive sequencing, genotyping, microarray, and bioinformatics services to global researchers. The company delivers end-to-end workflows — from experimental design and sample preparation through library construction, sequencing on Illumina, PacBio SMRT, and Oxford Nanopore platforms, to bioinformatics analysis and data interpretation. Service categories span genomics, transcriptomics, epigenomics, microbiome, single-cell, spatial multi-omics, and population genetics.

Product overview

CD Genomics provides a comprehensive omics services platform encompassing next-generation sequencing (NGS), long-read sequencing (PacBio SMRT and Oxford Nanopore), genotyping, bioinformatics analysis, and microarray services. The core offering includes Genomics Sequencing, Transcriptomics, Epigenomics, Microbiome, and Single-Cell Sequencing services, supported by PacBio SMRT Sequencing and Nanopore Sequencing platforms for long-read applications. The Nanopore Full-Length Transcriptome Sequencing service covers four complementary approaches: cDNA, lncRNA, Direct RNA, and TAIL Iso-seq. Additional services include Population Genetics, Spatial Multi-Omics Sequencing, Gene Therapy Solutions, and a Bioinformatics Cloud Platform. The company recently launched a Microbial Single-Cell Sequencing Service utilizing MobiNova™-100 and MobiNova™-M1 systems, positioning itself among the few global providers of this technology. All services are offered for research purposes only.

Differentiator

Problem solved

Functional benefit

Products and services

• Next Generation Sequencing (NGS) Services Comprehensive high-throughput DNA and RNA sequencing services using Illumina platforms, providing genomics, transcriptomics, epigenomics, microbiome, single-cell, and genome editing sequencing solutions for research applications.
• PacBio SMRT Sequencing Long-read single-molecule real-time sequencing service using Pacific Biosciences technology, enabling genome de novo assembly, full-length transcript sequencing, and detection of DNA modifications with average read lengths up to 15 kb.
• Nanopore Sequencing Long-read sequencing service using Oxford Nanopore Technologies for full-length transcripts, direct RNA sequencing, amplicon sequencing, and ultra-long reads spanning entire genomic regions.
• Nanopore Amplicon Sequencing Service Full-length amplicon sequencing service capturing targets such as 16S rRNA, ITS, and custom gene regions using Oxford Nanopore PromethION/GridION platforms with Kit 14 chemistry and R10.4.1 flow cells for species-level microbial profiling.
• Nanopore Direct RNA Sequencing Service Single-molecule, PCR-free direct RNA sequencing that reads native RNA molecules without reverse transcription, preserving real-world base modifications (m6A/m5C/Ψ/I) and providing poly(A) tail length measurements at single-molecule resolution.
• Nanopore Full-Length Transcriptome Sequencing Comprehensive full-length transcriptome sequencing covering cDNA, lncRNA, Direct RNA, and TAIL Iso-seq approaches, enabling isoform-level resolution, alternative splicing analysis, and native RNA modification detection from a single Oxford Nanopore platform.
• Genotyping Services Comprehensive SNP genotyping services including whole genome SNP genotyping, SNP fine mapping, CNV genotyping, DNA fragment analysis, APOE genotyping, cell line identification, and parentage testing using multiple technology platforms.
• Bioinformatics Services NGS data analysis and interpretation services covering genomic data analysis, transcriptomic data analysis, epigenomics data analysis, and long-read sequencing data analysis with customized bioinformatics solutions.
• Microarray Services Transcriptomics, genomics, and DNA methylation microarray services including gene expression profiling, SNP genotyping arrays, and methylation analysis using Illumina platforms.
• Single-Cell Sequencing Single-cell resolution sequencing services including scRNA-seq, scDNA methylation, scDNA sequencing, scTCR/BCR-seq, scATAC-seq, 10x Genomics single-cell sequencing, and microbial single-cell sequencing.
• Spatial Multi-Omics Sequencing Spatially resolved transcriptomics services using Stereo-seq, 10x Xenium In Situ, 10x Visium HD, and 10x Visium FF platforms for spatial gene expression analysis.
• Microbial Single-Cell Sequencing Service Advanced microbial research technology enabling analysis of individual unculturable microbial cells using MobiNova-100 and MobiNova-M1 systems, covering Microbial Single-Cell RNA Sequencing and Microbial Single-Cell Genome Sequencing workflows.
• TAIL Iso-seq Service Full-length transcript sequencing with intact poly(A) tail preservation enabling per-molecule measurement of poly(A) tail length, alternative polyadenylation (APA) site usage, and non-A residue detection at isoform resolution.
• Population Genetics Services Population-level genetic analysis services including genome-wide association studies (GWAS), pan genome analysis, variant calling, population evolution, genetic linkage mapping, bulk segregant analysis (BSA), and QTL-seq.
• Bioinformatics Cloud Platform Cloud-based bioinformatics analysis platform for processing and interpreting NGS and long-read sequencing data with integrated analysis tools and secure data management.
• Epigenomics Services Comprehensive epigenomic analysis services covering DNA methylation (bisulfite sequencing, WGBS, 5mC/5hmC), histone modifications (ChIP-seq), RNA methylation (MeRIP-seq m6A), ATAC-seq, and other epigenetic modifications.

Quantifiable outcome

• Species-level identification achieved with full-length 16S rRNA (V1-V9) and ITS regions, compared to genus-level resolution from short-read methods
• +3 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Academic Institutes (partnerships for technology validation)minorStrategic or Co-development PartnerCD Genomics has established technology and product validation through multiple partnerships with academic institutes, diagnostic companies, and testing laboratories. These partnerships validate their technologies and expand research applications. While no specific named partners were identified, the company references 'multiple partnerships with the academic institutes, diagnostic companies, and testing laboratories' as validation of their technologies.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/CDGenomics2005
• Facebookfacebook.com/1433298210256701
• LinkedInlinkedin.com/company/cd-genomics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CD Genomics